Skip to main content
S&P 5007,551.81-0.45%DOW51,461.90-1.21%NASDAQ25,978.42-0.01%BTC$76,346.00+0.85%ETH$2,420.07+0.87%GOLD$4,327.00-1.38%OIL$101.32-1.08%
Smart Investors Daily
SI

NASDAQ · SINT

Sintx Technologies, Inc.

Healthcare · Medical - Devices

$1.68

Down-$0.02 (-1.18%)

Updated Sep 17, 2026, 3:49 AM

SID Score

4.5/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
10.72M
P/E ratio
-0.7
Dividend yield
0.00%
52-week range
$1.40 – $5.14
Volume
7.35K
Avg. volume
199.8K

Price performance

SINT price history

1M range · 20 trading sessions · Daily adjusted prices

SINT closed at $1.68 after 20 trading sessions, up 5.66% for the selected period.

Last close
$1.68
Period change
+5.66%
Period low
$1.49
Period high
$1.86
Daily close
View OHLC price history
SINT OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 16, 2026$1.745$1.745$1.67$1.687.35K
Sep 15, 2026$1.77$1.78$1.68$1.7011.93K
Sep 14, 2026$1.6801$1.79$1.6801$1.799.75K
Sep 11, 2026$1.86$1.86$1.73$1.8017.71K
Sep 10, 2026$1.82$1.935$1.82$1.8637.73K
Sep 9, 2026$1.715$1.82$1.6701$1.8230.96K
Sep 8, 2026$1.69$1.7999$1.63$1.7430.33K
Sep 4, 2026$1.54$1.69$1.5101$1.6343.65K
Sep 3, 2026$1.49$1.54$1.48$1.5413.1K
Sep 2, 2026$1.489$1.54$1.48$1.5218.64K
Sep 1, 2026$1.51$1.51$1.4602$1.4924.92K
Aug 31, 2026$1.50$1.56$1.50$1.5333.59K
Aug 28, 2026$1.51$1.531$1.48$1.5018.63K
Aug 27, 2026$1.56$1.58$1.51$1.5351.4K
Aug 26, 2026$1.55$1.585$1.53$1.5812.58K
Aug 25, 2026$1.5227$1.56$1.52$1.5623.55K
Aug 24, 2026$1.57$1.57$1.51$1.5316.03K
Aug 21, 2026$1.54$1.58$1.4884$1.5525.47K
Aug 20, 2026$1.6179$1.6179$1.46$1.5153.46K
Aug 19, 2026$1.63$1.65$1.55$1.5956.11K

Latest SINT news

The latest Smart Investors Daily articles mentioning SINT.

Stock researchCompany · Overview

SINT research

Overview

Company profile and research snapshot.

Company profile

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$25.50
Implied upside
—
Analysts
7
SINT recent ratings
DateFirmRatingTarget
Jun 4, 2026Maxim GroupBuy—
May 20, 2026HC Wainwright & Co.Buy—
Apr 13, 2026HC Wainwright & Co.Buy—
Apr 8, 2026Ascendiant CapitalBuy—
Dec 8, 2025Ascendiant CapitalBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 8, 2026

SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

SALT LAKE CITY, Utah, Sept. 08, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company commercializing proprietary silicon nitride technologies across medical and other high-value applications, today announced that it will participate in the 28th Annual H.C. Wainwright Global Investment Conference, taking place September 14–16, 2026, at the Lotte New York Palace Hotel in New York City. Gregg Honigblum, Chief Inve

Benzinga · Aug 13, 2026

SINTX Technologies Regains Nasdaq Compliance

SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a company focused on advanced silicon nitride materials and medical technologies, today announced that it received written notification

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By